News & Upcoming Events
[Press Release] FluChip-8G® Insight Evaluated for Enhanced Influenza Surveillance in Southeast Asia InDevR collaborating with Armed Forces Research Institute of Medical Sciences to test FluChip-8G Insight™ BOULDER (12/4/18) — InDevR ...
Read More
Read More
FluChip-8G Tested in US and China for Rapid Characterization of Influenza Viruses Duke and Duke Kunshan University collaborating with InDevR Inc. to test the new influenza subtyping assay for ...
Read More
Read More
[Press Release] InDevR’s VaxArray Platform to Tackle Measles-Rubella Vaccines VaxArray to improve potency testing for MR vaccines with support from Bill & Melinda Gates Foundation BOULDER (11/8/18) — InDevR announced ...
Read More
Read More
[Press Release] VaxArray Potency Kit for “Pandemic” Vaccines Fills Gap in Pandemic Preparedness InDevR’s game-changing VaxArray potency test for influenza H5, H7, and H9 vaccines published in npj Vaccines ...
Read More
Read More
[Press Release] First Influenza-Specific Neuraminidase Test Kit InDevR’s game-changing VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines BOULDER COLORADO (6/12/18) ...
Read More
Read More
